Clinical trial Recruiting at 1 site Interventional Ages 18 to 44 Women only

Over-the-counter pain medicine comparison for period cramps in women with Crohn's disease

Official title: Acetaminophen Versus Ibuprofen for Discomfort in Crohn's Disease (AVID-CD): An Open-Label Randomized Pilot Trial

Run by University of North Carolina, Chapel Hill · NCT07337902 · Data updated 2026-11-12

This pilot will test whether ibuprofen or acetaminophen relieves period cramps more effectively and safely for women aged 18–44 who have Crohn's disease in remission.

More Crohn Disease (CD) trials

Quick facts

Study typeInterventional
Ages18 Years to 44 Years
SexWomen only
Enrollment24 (estimated)
SponsorUniversity of North Carolina, Chapel Hill
Academic / other
Locations1 site (Chapel Hill, North Carolina)
StatusRecruiting
StartedMarch 18, 2026
Main results expectedJuly 2028
Study endsJuly 2028
Registry record updatedJuly 14, 2026
Trial IDNCT07337902 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people assigned female at birth, aged 18–44, with a confirmed Crohn's disease diagnosis who are in stable remission (CDAI <150), have regular menstrual cycles and primary dysmenorrhea, and are using reliable contraception or abstinence.

Probably not a fit

Those unlikely to benefit include people with active Crohn's disease, current pregnancy, other pelvic pathologies (for example endometriosis or fibroids), recent or unstable hormonal contraceptive use, or anyone outside the specified age or sex-at-birth criteria.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot enrolls people assigned female at birth, ages 18–44, with Crohn's disease in stable clinical remission and self-reported primary dysmenorrhea. Participants complete a screening visit with a blood draw, pregnancy test, stool testing, a physical exam, and questionnaires, then continue the rest of the study at home. They will be assigned to take either ibuprofen or acetaminophen for four menstrual cycles and asked to submit samples and complete surveys. Investigators will track feasibility outcomes including recruitment, adherence to the medication plan, retention through the study, and completion of study activities to inform a larger trial.

Why it matters

Potential benefit: If successful, the project could clarify which common over-the-counter pain medicine provides better period-cramp relief without worsening Crohn's disease, giving clearer guidance for symptom management.

How similar studies have gone: There is limited prior research directly comparing ibuprofen and acetaminophen for menstrual pain specifically in people with Crohn's disease, and concerns about NSAID effects on IBD make this a relatively novel and cautious pilot approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ages 18-44 years
* Assigned female at birth
* Crohn's Disease (CD) diagnosis
* In stable clinical remission from CD, defined as a short Crohn's Disease Activity Index (CDAI; See Table 3) \<150 without use of corticosteroids
* Self-reported primary dysmenorrhea
* Regular menstrual cycles occurring every 23-35 days
* Using an appropriate contraceptive method or abstinence

Exclusion Criteria:

* Any of the following conditions: endometriosis, adenomyosis, polycystic ovarian syndrome, endometrial fibroids/polyps, chronic pelvic inflammatory disease, a history of pelvic surgery including hysterectomy, any other pathological pelvic conditions, or current pregnancy
* Plans to become pregnant during the study period
* Use of an oral contraceptive for less than 3 months, on an unstable oral contraceptive dose within the last 3 months, switched from one oral contraceptive to another within the last 3 months or intend to do so during the course of the trial
* Taking hormone therapy including estrogen or progesterone that is not part of a hormonal contraceptive
* Known hypersensitivity or contraindication to ibuprofen or acetaminophen
* Inability to complete REDCap questionnaires (including confusion despite training and/or lack of smart phone and/or computer access).
* Not able to speak and read English language.

Where it's running

  • University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina, United States
    Recruiting

Study contacts

  • Principal investigator: Erica J Brenner, MD, MSCR — University of North Carolina, Chapel Hill

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.